To investigate the mechanisms by which tumor-infiltrating lymphocytes exert their antitumor effects, tumor-specific tumor-infiltrating lymphocyte clones, as well as autologous tumor cell lines from primary and secondary tumors of two patients during the course of melanoma progression were established. Enrichment for tumor-infiltrating lymphocytes expressing CD25, as well as low concentrations of interleukin-2 (30 IU Iml) in the culture medium, led to a preferential outgrowth of cells that express the high-affinity interleukin-2 receptor. All of these expressed CD2, CD3, CDll, and CD25. Coculture of tumor-infiltrating lymphocyte clones with irradiated, autologous tumor cells induced an up to 480% greater proliferative responses than recombinant interleukin-2 alone. Approximately 60% of the tumor-infiltrating lymphocyte clones showed cytotoxicity against the relevant tumor in a 4-h StCr-release assay. When tested in an T umor cells are known to express antigens that playa decisive role in the process of recognition and rejection of tumors by the host immune system [1] . In human melanoma, a high degree of phenotypic heterogeneity has been shown to exist not only among tumors derived from different patients, but also between autologous primary and metastatic lesions, among different metastases removed from the same patient, and even among clones isolated from the same cell line [2] [3] [4] [5] . The accumulation of lymphocytes, predominantly T cells, at tumor sites may reflect an immunologic recognition of the neoplasm by the host, suggesting a specific function of tumor-infiltrating lymphocytes (TILs) directed against antigenic determinants present on tumor cells [6] [7] [8] [9] . The study of the nature of cells infiltrating the tumor may thus provide insight into the complex issue of tumor-host interactions.
The mechanisms by which TILs exert their antitumor effects iI, vivo are unknown, although recent evidence suggests a correlation between the irl vitro property of autologous tumor lysis and therapeutic response [10] [11] [12] [13] [14] . It has been shown that infused 1IlIn-labeled TILs traffic specifically to tumor deposits, and thus it is possible that TILs exert their effects via direct tumor contact and lysis [15] . AlterManuscript received May 5,1992 ; accepted for publication February 10, 1993 .
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18-h StCr-release assay, the number of tumor-infiltrating lymphocyte clones exhibiting cytotoxicity against the relevant tumor increased to over 85% . In response to autologous tumor cells, nine of 15 clones secreted interferon-y, tumor necrosis factor-a, or both. Cytokine production was not restricted to either CD4+ or CD8+ T cells because both CD4+ and CD8+ tumor-infiltrating lymphocyte clones secreted cytokines. Tumor-infiltrating lymphocyte tumor interaction appears to be lesion specific because induction of proliferation and cytokine production, as well as susceptibility to cytolysis, was found not only restricted to the autologous system, but also to the specific lesion. The pattern of tumor-infiltrating lymphocyte tumor interaction specificity indicates a possible loss of antigens expressed on the tumor during disease progression. ] Invest Dermatol 101: 15 -21 J 1993 natively, TILs may initiate factors that destroy tumor cells or that recruit other elements of the immune system for this task. It has been shown that interleukin-2 (IL-2) -activated TILs produce mRNA for various cytokines, including granulocyte-macrophage colony-stimulating factor, tumor necrosis factor (TNF)-a, and TNF-P [16] . Although many studies documenting cytokine release by T lym,Phocytes stimulated wit~l polyclonal activators have been reported l17 -19], only a few studtes addressed the specific response of human T cells to tumor by this mechanism [20, 21] .
In melanoma, it is possible to obtain effectors both reactive against a large target cell repertoire, and therefore unrestricted by products of the major histocompatibility complex, and that recognize and kill the autologous neoplastic cells in a major histocompatibility complex-restricted fashion [9-14,22,23J . Because many of the T cells infiltrating tumors may not necessarily be involved in anti-tumor effector functions, it is important to establish a functional role for the T cells under investigation. The technology of cloning functional T-cell subsets il1l1itro has proved to be a powerful tool in studies of cellular immune response to cell-surfaceassociated antigens [4,24 -29] . Selection of T cells expressing the high-affinity IL-2 receptor for cloning, as well as using cloning conditions with low concentrations of IL-2, has been suggested to give a greater yield of tumor-specific T -cell clones than the standard cloning protocol [30] .
The objectives of our study were 1) to develop autologous tumorspecific T -cell clones from the TILs of primary and secondary melanoma; 2) to investigate the specificity of T-cell response against autologous tumor cell lines; and 3) to investigate the mechanisms used by these T cells during T -cell-tumor interaction. We report 0022-202Xj93jS06.00 Copyright © 1993 by The Society for Investigative Dermatology, Inc. • O nl y parts of the tumor were used for generation ofTILs.
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• As percent of the total of cells yielded. , Secondary tumor occurred 9 months after the primary tumor at a distant site. J Secondary tumor was present w hen primary tumor was diagnosed. , Tumor tissue was segregated frolll unaffected lymphatic tissue insofar as macroscopicall y possible.
here that stable, autologous tumor-specific T-cell clones can be derived from TILs of primary and secondary melanoma usin g a cloning protocol that favors the growth of T cells expressing the high-affinity IL-2 receptor. The majority of these clones were capable of mediating a specific response to the relevant tumor-inducing proliferation, cytotoxicity, and interferon-y (I FN-y) and TNF-a production by them.
MATERIALS AND METHODS
Melanoma Cell Lines [31] Dispersed cells were obtained by grating tumor fragments from freshly resected melanomas against a 0.3 X 0.3-mm metallic m esh immersed in complete medium consisting of RPM I 1640 supplemented with 10% fetal bovine serum (FBS) , 1 % penicillin, 1 % streptomycin, 1 % glu tamine, and 1 % sod ium pyruvate. A portion of these cells was frozen for late r use in T-cell stimul ation and cytotoxicity assays. The remaining cells were plated into six-well collagen-coated culture plates at 2000 cells/ well in complete mediuin and grown in humidified incubators at 37°C with 5% CO 2 , Fibroblast contamination was suppressed by addi ng geneticin (250 ,ug/ml) (G ibco BRL, Berlin, Germany) . During the initial 3 weeks of growth, 25% of the spent medium was removed and replaced three times a week. Tumor lines w ere maintained as monolayers and passaged by trypsinization with 0.0625 % trypsin plus eth yl~n ediamin~tetraacetic acid as required . Characteristics of tumor leSIO ns and yIeld of cells are gIven 111 Table I. Preparation ofTILs [32] Tumor cell suspensions were prepared by mincing freshly resected tumors into small pieces that were digested for 12 h in RPMI 1640 medium supplemented with 5% FBS, 1 % penicillin/streptomyc1l1, 1 % glutam1l1e, and 1 % sodIUm pyruvate containing 0.1 % collagenase type IV (200 U / g) and 0.005% deoxyribonuclease type I (100 U/mg) (Sigm a Chemicals Co., St. Louis, MO) and then passed through a steel sieve. After washing rwice with Hanks' balanced salt sol ution, viable cells were separated on a Ficoll/Hypaque grad ient at 600 X g for 20 min, washed rwice, counted, and placed into six-well tiss ue culture plates 111 complete medium at a concentration of 5 X 10 5 cells/ml. Complete medium was supplemented with IL-2 (30 IU/ml) (Eurocetus, Amsterdam, The N etherlands). C haracteristics of tumor lesions and yield of TILs are given in Table I .
Immunomagnetic Isolation of CD25+ Cells The indirect immunomagnetic isolation of CD25+ cells has been described in detail elsewhere [33] . Briefly, the TILs were suspended in complete medium at a concentration of 10 8 cells/ml. Thereafter, 0 .1 m g CD25 monoclonal antibody (MoAb)/10 6 TILs were added, and the cells were incubated for 1 h at 4 ° C. The cells were washed twice in Hanks' balanced salt solution, resuspended in complete medium, and incubated with sheep anti-mouse immunoglobulin-G (I gG) -coated Dynabeads M-450 (Dynal, Oslo, Norway) (7.5 X 10 5 beads/ l0 6 peripheral blood mononuclear cells) for 30 min with gentl e rotation. Cells attached to Dynabeads were recovered with THE J OURNAL OF INVESTIGATIVE DERMATOLOGY the MPC-6 magnet (D ynal) and washed three times in complete medium. T he cell/bead suspension was incubated for 24 h at 37"C, resu lting in detachment of most of the beads from the cells. Thereafter, the cells were separated from the beads usi ng the MPC-6 magnet. T he efficiency of cell separation was confirmed by flo w cytometry (less than 5% contaminating cells).
Generation of Cloned Human TIL lines TIL clones were obtained using a limiting dilution technique [24] by plating 0.5 cells/ well onto a feeder layer of 5000 autologous, irradiated (50 Gray) melanoma cells-obtained from the sa me tumor specimen-and 5000 irradiated (50 Gray) cells of the Epstein-Barr virustransformed B-cellline LAZ 509 per well. Only CD25+ TILs were used for cloning . Colonies were expanded by addition of culture medium containing recombinant IL-2 (rIL-2) (30 IU /ml) every 3 d. The culture m edium consisted of RPMI 1640 suppl emented with 20% human AB serum, 1 % penicillin/streptomycin, 1 % glutamine, and 1 % sodium pyruvate. All cell lines used in this study were subcloned at least three times at 1000 cells/well. The phenotypes of TIL lines used in this study are summarized in Table II . TIL lines were designated pT if derived from a primary tumor and sT if derived from a secondary tumor. T he use of the limiting dilution technique for cloning is widely accepted as a standard protocol to obtain clonal cell lines, but each clone has to be suspected of being polyclonal [34] .
Human Leukocyte Antigen Phenotyping Peripheral blood lymphocytes were collected from 20 ml of heparinized blood by density gradient centrifugation, washed w ith RPMI/Tris(hydroxymethyl)aminomethane (Tris) (RPMI 1640 and Tris buffer 60 mM, pH 7.45, 1 + 1), and resuspended in 2 ml of RPMI/Tris supplemented with 5% FBS. A 2-ml plastic syrin ge filled with 0.14 g nylon wool (Baxter Deutschland GmbH, Unterschleissheim, Germany) was rinsed with RPMI/Tris/FBS 5% and incubated for 30 min at 37"C. The nylon wool column was overlaid with the cell suspension , and the syringe was sealed with parafilm and incubated for 45 min at 37°C. Afterward, T cells were rinsed into a plastic tube by addi ng 10 ml of phosphate-buffered saline, and B cells were squeezed from the syringe using 20 ml ofRPMI/Tris/FBS 10%. B and T cells were washed separatel y three times and adjusted to 2000 cells/,ul. The standard complement-dependent microlymphocytotoxicity test (Biotest Diagnostic, Munich, Germany) was carried out in microtiter trays with incubation times of 30 and 60 min for human leukocyte antigen (HLA) class I and 60 and 120 min for class II typing, respectively. The HLA phenotype of patient B was Al , A3, B7, B8, Cw7, DR2, DR3 and that of patient S was A2 A28, Bw53, Cw6, DRw13.
MoAbs MoAbs used in this study have been previously described in detail and are commercially available (Becton Dickinson, San Jose, CA; T Cell Science, Cambridge, MD) .
Phenotypic Analysis by Flow Cytometry Cells w ere washed twice with phosphate-buffered saline and then incubated with purified human IgG for 10 min to inhibit subsequent MoAb binding to Fc receptors. After washing as before, 10 6 cells were incubated for 30 min with the primary M oAbs. Following two washes with Hanks' balanced salt solution containin g 0.2% sodium azide, cells w ere stained for 30 min with Fab~ goat anti-mouse IgG fluorescein isothiocyanate conjugate. After washing as before, the cells were incubated for 20 min with excess mouse IgG to block free goat anti-mouse IgG-binding sites. The goat anti-mouse IgG and blocking steps were omitted for samples stained with directly fluorescein isothiocyanate-conju gated MoAbs . After the blocking step, phycoerythrin-conjugated MoAb was added for 30 min, followed by two additional was hes. All incubations and washes were performed at 40°C. Cells were analyzed with a FACScan (Becton Dickinson, San Jose, CAl (488 or 590 nm for fluorescein isothiocyanate and phycoerythrin, respectively). The noise threshold was se t to exclude volume signals below those of lymphocytes. All analyses were performed using photomultiplier voltages and gain settings that were standardized by fluorescent calibration beads. All signals were pro-VOL. 101 , NO. I JULY 1993 TIL CLONES FROM HUMAN MELANOMA 17 • Phenotype of clones was determined by flow cytometry. , Proliferation was determined as described in Materials alld Methods; results arc given as average ± SD of three experiments. J Cytotoxicity was tested against autologous, lesion-specific rumor cells in a standard 4-h" Cr-release assay .
• As allogenic melanoma lines. lines from patient B were used for TIL clones from patient S and vice versa.
cessed using a logarithmic amplification. Irrelevant fluorescein isothiocyanate-conjugated mouse IgG2a MoAb controls were used to assess the degree of non-specific antibody binding to each cell preparation and to allow for the establishment of markers for distinguishing positive and negative cell populations.
Proliferation Assay The proliferative response was measured by culturing 5 X 10 4 cells/well for 2 d in flat-bottomed microtiter plates. Proliferation was quantified by 3H-thymidine uptake in triplicate, as previously described [30] .
Cytotoxicity Assay Cell-mediated lysis was meas ured in standard 4-and 18-h SICr-release assays, as briefly described below [19] . U-bottomed plates were used for cytotoxiciry assays in conjunction with RPMI 1640 supplemented with 10% FBS . Assays were performed at various effector/target ratios using 5 X 10 3 slCr-labeled target cells/well. Plates were incubated for 4 or 18 h, and a 70-JlI aliquot was then removed from each well , and the specific slCr_ release was measured. Results are expressed as follows:
where spontaneous release was assessed by incubating target cells in the absence of effector cells, and maximum release w as determined in the presence of 1 % Triton X-I00.
TNF-a and IFN-y Enzyme-Linked Immunosorbent Assay TNF-a and IFN-y concentrations were measured in cell-free supernatants by enzyme-linked immunosorbent assay (Endogen, Boston, MA) , as previously described [24] .
RNA Isolation and Northern Blot Analysis At different time periods following coculture of TIL clone pTB5 with the autologo us tumor cell line pMB , pTB5 and pMB cells w ere separated, and total RNA of pTB5 cells was prepared by ultracentrifugation over a CsCI cushion. Then 10 Jlg RNA/lane was size fractionated on a formaldehyde containing 1 % agarose denaturating gel and transferred to a nylon membrane (Amersham Hybond, Braunschweig, Germany). The probes were labeled using the random hexanucleotide priming technique. Hybridizations were carried out with 2.5 X 10 6 cpm/ml of hybridization solution [50% formamide, 5 X saline sodium phosphate ethylellediaminetetraacetic acid, 5 X Denhardt's solution, 0.1 % sodium dodecyl sulfate, and 100 Jlg/ml calf thymus DNA] at 42°C for 18 h. Filters were washed twice in 2 X saline sodium phosphate ethylenediaminetetraacetic acid, 0.1 % sodium dodecyl sulfate at room temperature for 15 min and twice in 0.1 X saline sodium phosphate ethylenediaminetetraacetic acid, 0.1 % sodium dodecyl sulfate at 65 ° C for 30 min. Filters were exposed on Kodak XAR-5 film for au toradiography [24] .
eDNA Probes IFN-y cDNA was a gift fro m Dr. Heinze (DRK Blutspendedienst, Springe, Germany). The T NF-a cDNA was kindly provided by Knoll AG (Ludwigs hafen, Germany) .
Statistical Analysis The student paired t test was used to determine the significance of differences between two groups. A result was considered significant if p < 0.01.
RESULTS
Generation of TIL Clones TIL clones were generated using a limiting dilution technique with low concentrations of IL-2 (30 IU /ml) . Selection of TILs expressing the p55 a-chain of the interleukin-2 receptor (IL-2R) fo r cloning increased the cloning frequency from 0.8 to 3.2 clones/96 wells.
The TIL clones were tes ted for cell-surface m arker expression using MoAbs against T-cell subsets. The results for the clones used in this study are summarized in T able II. All clones expressed CD2, CD3, CD11, and CD25. Approximately 33% of clones reacted with anti-CD4 MoAb and 66% w ith anti-CD8 MoAb. No correlation between the expression of CD4 or CD8 and the origin of the TIL clones from a primary or secondary tumor could be fou nd . In addition, testing for MoAb reactiviry directed against antigens mainly expressed on natural kil ler cells was perfo rmed. As expected, a number of clones showed a low reactiviry with anti-CD56 MoAb (40%), whereas none of the clones showed a high reactiviry with this MoAb (data not shown). Because CD56 is not a specific marker for natural killer cells in long-term cultures, we also used CD16 MoAb, which is thought to be more specific. N one of the clones showed CD16 expression.
Proliferation o f TIL clones was tested in response to irradiated (50 Gray) melanoma cell lines and low concentrations of rIL-2 (30 IU /ml) after a 48-h culture in complete medium without further stimulation. Under these conditions, rIL-2 alone (data not show n) or co-culture with heterogeneous melanoma cells was not sufficient to induce a good proliferative response (Table II) . Coculture of T IL clones with autologous, lesion-specific tumor lines and rIL-2 induced up to 460% greater proliferative response compared with rIL-2 alone. Melanoma cell lines derived from primary tumors were able to induce an enhanced proliferation of TIL clones in a nonlesion-specific way such that both TILs from primary and secondary tumors were activated . In contrast, melanoma lines from secondary tumors did not change the proliferative response of TIL clones from primary tumors.
Cytotoxic Activity of TIL Clones The TIL clones obtained under the conditions described above showed little or no natural killer activity as measured by the killing ofK562 (less than 10% lysis in an effector/target ratio of 40: 1, data not shown). Lymphokineactivated killer cell activity as determined by the ki llin g of Daudi ce lls ranged between 17% and 25% in an effector/target ratio of 40: 1 in a 4-h SICr-release assay for the following clones: pTB1, pTB5, sTB3, sTB6, pTS4, pTS7, sTS6, and sTS7 (data not shown). Table II documents the lytic activity of TIL clones agains t the autologous, lesion-specific tumor cell line. Sixty percent of TIL clones mediated cytotoxicity against the corresponding tumor cell lines, with up to 35% of specific lysis in a 4-h assay. The cytol ytic activity was not w holly restricted to CD8+ clones because sTS3 (a CD4+ clone) efficiently killed the autologous tumor cell line sMS. A number of TIL clones generated from metastatic tumors were able to lyse melanoma lines from primary tumors (sTB3, sTB6, sTS3, sTS6, sTS7), whereas none of the clones from primary tumors were ab le to kill tumor lines from metastatic tumors (Fig 1) .
TIL clones pTB3, sTB2, pTS8, and sTS4, which showed no specific lysis in the standard 4-h 51Cr-release assay against the autologous tumor lines, were effective in killing those lines in an 18-h assay (Fig 2) .
Specific Cytokine Production of TIL Clones in Response to
Autologous Tumor Cell Lines To assess cytokine production by T IL clones, stimulation with autologous, lesion-specific melanoma lines was performed. Cytokine production by the tumor cells was exclud ed by separation of TIL clones from tumor lines after a 6-h co-culture. IF N -y and TNF-a concentrations were measured in cell-free supernatants after a 24-h culture. Nine of 15 clones secreted increased amounts of IFN-y, T N F-a, or both cytokines (seven of 15 clones) in response to the relevant tumor (Table III) . Although most T IL clones secreted small amounts of IFN-y (average 105 U/ml) and TNF-a (average 219 pg/ml) cO~lstitutive ly , secretion was significantly enhanced by stimulation With the releva nt tumor cell line (maximum 331 U / ml and 937 pg/ml; p < 0.01) (Table III) in these TIL clones. For allogeneic tumor linesor tumor lines ge nerated from secondary tumors w hen TIL clones obtained from primary tumors were used -no major changes in the secretion ofIFN-y and TNF-a were observed . However, melanoma lines from primary tumors were ab le to stimulate cytokine produ~ tion in autologous TIL clones generated from metastases (maxImum 310 U/ml and 886 pg/ml; p < 0.01 ). Hybridization of poly(A)-enriched RNA from TIL clone pTB5 obtained immediately, 2, 4, 12, and 24 h following coculture with the irradiated autologous tumor line pMB using cDNA probes for IFN-y and TNF-a revealed that peak mRNA accumul ation for IFN-y occurred after 4 h and for TNF-a after 12 h (Fig 3) . To exclude the possibility t hat mRNA accumulation for IFN-y and TNF-a occurred in the tumor cells themselves, pTB5 was separated fro m pMB prior to RNA isolation.
DISCUSSION
In this study, tumor-specific TIL clones were isolated from primary and secondary mel anomas from two patients during their course of disease progression. C lones were isolated under cultu re conditions t hat preferentiall y allowed the outgrowth of cells t hat express the high-affinity IL-2R. This aim was ac hieved by enrichment ofTILs expressing CD25 and low concentrations of IL-2 in the culture medium. This approach was chosen because expression of the highaffin ity IL-2 R on T cells may be a sign of their involvement in anti-tumor functions [8, 30] . Antigenic ch allenge of the T-cell receptor mediates tanscriptional activation of both the IL-2 as well as ..
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..--e: TIL clones pTBl, pTBS, sTB3, sTB6, pTS4, pTS7, sT S3 , and sTS7 were tested for cytotoxicity against autologous tumor cell lines derived from primaty (squares) or secondaty (circles) tumors and heterolo gous tumor lines from primary tum ors (triallgles). Cell -mediated lys is was meas ured in a standard 4-h 5lCr-release assay, as described ill Materials alld Methods, using different effector/target ratios ranging from 1 : 10 to 1 : 40. Results are expressed as average ± SD of three experiments.
the IL-2R ge nes. This makes T cells competent to receive cell cycle progression signals that lead to clonal expansion of the antigen-specific cells [35] [36] [37] [38] . TIL clones obtained under these conditions were tes ted in antigen-dependent proliferation assays, as proposed by Degiovanni et III [4] . W e confirmed their findin gs, showing that tumor-specific Tcell clones can be reactivated to proliferation with small numbers of releva nt melano ma cells. Phenotypic analysis showed that these TIL clones excl usively express T-cell markers with a CD4/CD8 ratio of 0.5. Approximately 60% of the TIL clones showed cytotoxicity against the relevant tumor in a 4-h StCr-release assay. No efficient killing of heterologous tumor cells was detected. When tested in an 18-h 51Cr-release assay, the number of TIL clones that were cytotoxic against the relevant tumor increased to over 85%. Measurement of IFN-y and TNF-a in culture supernatants of TIL clones following stimulation with the relevant tumor revealed that nine of 15 clones secreted increased amounts ofIFN-)', TNF-a, or both cytokines in response to tumor cel ls. These findings could be confirmed by detecting an acc umulati on of mRNA for these cytokines in TIL clones after stimulation with rel evant tumor cells. This Schwartzentruber et 01 [21] who demonstrated the specific release of proinflammatory cytokines by TILs in bulk cultures in response to autologous tumor cells . We were able for the first time to reproduce their findings on a clonal level. In addition, we clearly demonstrated that cytokine production is not restricted to either CD4+ or CD8+ T cells because both CD4+ and CD8+ TIL clones secreted these cytokines. Because both IFN-y and TNF-a have direct tumoricidal activities against melanoma cells, coupled with all TIL clones secreting these cytokines showing cytotoxicity against the relevant tumor (in either the 4-h-or the 18-h 51Cr-re1ease assay), it is proposed that the cytokine production in specific response to the tumor is one of the mechanisms by which TILs exert their tumoricidal activity. For melanoma, a high degree of phenotypic heterogeneity exists. This has been shown 1) among tumors derived from different patients', 2) between autologous primary and metastatic lesions; 3) among different metastases removed from the same patient; and 4) among clones isolated from the same cell lines [2 -5] . Guerry and co-workers have previously shown that cell lines cultured from lesions early in the pathway of melanocytic tumor progression (i.e., TIL CLONES FROM HUMAN MELANOMA 19 radial growth phase) stimulate autologous T-cell proliferation ill Il irro by presentation of soluble tetanus toxoid, whereas cell lines derived from late me1anocytic lesions (i.e., vertical growth rhase of primary melanoma) do not [39] . In addition, a variety 0 studies have demonstrated the heterogenous susceptibility of melanoma clones to lysis by autologous cytotoxic T lymphocytes [2, 11, 27, 40] . Susceptibility to lysis by autolo gous cytotoxic T lymphocytes has not been directly correlated with the presence or absence of any particular surface antigen; nevertheless, it has been postulated that differential antigen expression may facilitate the escape of tumor sub populations from immunologic recognition [1 ,40] .
Although this study concentrated on the effector functions of TIL clones, and we only investigated a low number of tumor lesions from the same patients, it is obvious that the melanoma cell lines show some heterogeneity in their ability to stimulate proliferation and cytokine production in TIL clones, as well as in their susceptibility to cytolysis. If TIL clones were co-cultured with autologous, but not lesion-specific tumor cells, melanoma lines from primary tumors were sufficient to induce a strong proliferative response, as well as IFN-y and TNF-a production in TIL clones from secondary melanoma. In contrast, melanoma lines obtained from metastatic tumors were unable to induce a proliferative response or cytokine production greater than that induced by rIL-2 alone in TIL clones derived from the autologous primary. TIL clones generated from metastatic tumors were able to lyse melanoma lines from primary and metastatic tumors, w hereas none of the clones from primary tumors were able to kill tumor lines from metastatic tumors. Our findings confirm previous reports and additionally point out the complexity of host anti-tumor immunoresponse and tumor-escape mechanisms because the immune system seems to be able to react against tumor cells that escaped from the first-line anti-tumor immune response ;11 vivo . The mechanisms by which tnelanomas may escape immunosurveillance are not yet clear but may involve shedding of membrane molecules, such as intercellular adhesion molecule-I, the loss of major histocompatibility complex molecules, or defects in antigen presentation [40] [41] [42] [43] [44] .
In summary, it was demonstrated in this study that stable autologous tumor-specific T-cell clones can be derived from TILs of primary and secondary melanomas using a cloning protocol that favors the growth ofT cells expressing the high-affinity IL-2R. The majority of these clones were capable of mediating a specific response to the relevant tumor, inducing proliferation, cytotoxicity, and IFN-y and TNF-a production by them. This confirmed recent reports concerning cytokine production of bulk-cultured TILs in response to autologous tumor for the first time on a c!onallevel. This approach enabled us to further specify the characteristics of those • Cywkine production was measured in specific enzyme-linked immullosorbent assays, as described in Materials alld Methods; remIts arc given as average of three experiments.
so did not exceed 10%. NO, not detectable.
I Abbreviations as in Table II . pTB5 was separated from pMB prior to RNA isolation.
cytokine-producing cells. The selection of IL-2R -expressing cells for cloning seems to increase th e fidelity of generating tumor-specific T-cell clones. On the basis of this concept, activation and expansion protocols can be modified, enabling more efficient generation of cytotoxic lymphocytes for anti-tumor immunotherapy .
